Here’s what caught your eye on M&A / acquisitions in your 📃 VC Landscape & News database between 2023–2025 (based on items whose titles explicitly signal acquisition / M&A activity).
Themes that show up repeatedly
- Biopharma + AI capability tuck-ins (platform/compute/chemistry)
- Ginkgo acquiring Reverie Labs (AI-driven drug discovery platform).[2]
- Recursion acquiring Cyclica and Valence (chemistry + genAI capabilities).[3]
- SandboxAQ acquisition of Good Chemistry (AI simulation / drug discovery + materials).[4]
- Diagnostics consolidation
- Natera acquiring Foresight Diagnostics (up to $450M).[5]
- Tempus acquiring Paige ($81.25M).[6]
- Climate / industrial / infrastructure scale plays
- CRH acquiring Eco Material Technologies for $2.1B (appears twice in your saves).[7][8]
- Gevo acquiring Red Trail Energy assets (low-carbon ethanol + CCS footprint).[9]
- Ag / bio inputs and strategic control
- Bayer acquiring a majority stake in CoverCress.[10]
- Givaudan acquiring parts of Amyris’ ingredients portfolio.[11]
- ICL Growing Solutions acquiring Lavie Bio.[12]
- Biobest pursuing South America expansion via acquisition (Biotrop).[13]
- “Special situations” / financial-led M&A
- First Citizens acquiring failed SVB from the FDIC (systemic-event-driven deal).[14]
- EQT to acquire Seven Seas Water Group (PE acquisition framing).[15]
A couple “meta” M&A items you saved (not a specific deal)
- A framework-ish piece: “There Are Two Types of M&A …” (suggests you were thinking about M&A as a tool/strategy, not only tracking transactions).[16]
- A paid program link on “Accelerate Transformation Through Acquisition” (more “M&A as operating strategy”).[17]
If you want, I can tighten this further to “the highest-signal ones” by filtering to items you marked Read = true (right now, the M&A-titled items above appear to be mostly unread in the database).